Skip to main
CL
CL logo

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 28 analyst ratings
Buy
Strong Buy 29%
Buy 29%
Hold 36%
Sell 4%
Strong Sell 4%

Bulls say

Colgate-Palmolive has demonstrated a solid performance, with organic sales growth of 4.3% in the most recent quarter, driven by volume growth of 2.5% and pricing increases of 1.8%. The company has also shown a strong position in the global market, holding a 41.4% share of global toothpaste sales and a 32.2% share of global manual toothbrush sales, both reflecting year-over-year increases. Furthermore, management's expectations for accelerating organic growth in the second half of 2025, bolstered by favorable comparisons and contributions from foreign exchange-related pricing, signal a robust outlook for sustained sales growth and market share expansion.

Bears say

Colgate-Palmolive reported organic sales growth of only 4.3%, which fell short of the consensus expectation of approximately 6%, indicating a potential further decline in growth to around 3% in the first half of 2025. The company's gross margin performance in the fourth quarter of 2024 was below consensus, and while guidance suggests expansion in 2025, it is expected to be significantly lower than the 240 basis points achieved in 2024, resulting in reduced reinvestment flexibility. Moreover, the firm's pet care segment experienced a disappointing growth rate of 2.8% driven by volume declines, compounded by adverse foreign exchange impacts and sequential deceleration in both emerging and developed markets.

Colgate-Palmolive (CL) has been analyzed by 28 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 29% recommend Buy, 36% suggest Holding, 4% advise Selling, and 4% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 28 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Aug 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $93.21, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $93.21, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.